MONDAY, Oct. 21, 2024 -- Treating hospitalized patients with bloodstream infections with antibiotics for seven days is noninferior to treating for 14...
Vous n'êtes pas connecté
MONDAY, Oct. 28, 2024 -- For patients with a history of overt hepatic encephalopathy (OHE), rifaximin monotherapy (MT) results in significantly fewer OHE episodes than lactulose (LAC) MT, according to a study presented at the annual meeting of the...
MONDAY, Oct. 21, 2024 -- Treating hospitalized patients with bloodstream infections with antibiotics for seven days is noninferior to treating for 14...
WEDNESDAY, Oct. 30, 2024 -- Hypertension is the most common cardiovascular disease (CVD) comorbidity seen among dialysis patients globally, according...
THURSDAY, Oct. 31, 2024 -- Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in...
TUESDAY, Oct. 22, 2024 -- For patients receiving mirvetuximab soravtansine (MIRV) treatment for primary gynecologic malignancies, corneal toxicity is...
FRIDAY, Oct. 25, 2024 -- Delabeling patients with syphilis who believe they are allergic to penicillin is safe, according to a study presented at the...
MONDAY, Oct. 28, 2024 -- Many patients with cancer diagnoses experience lasting financial difficulties, according to two studies presented at the...
WEDNESDAY, Oct. 23, 2024 -- One year of valacyclovir is beneficial for patients with herpes zoster ophthalmicus (HZO), according to a study presented...
THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in...
TUESDAY, Oct. 22, 2024 -- Artificial expiration dates on eye drops in ophthalmology clinics result in significant waste in terms of medication,...
THURSDAY, Oct. 24, 2024 -- Malnutrition is more likely among patients undergoing multiple orthopedic surgeries, according to a study presented at the...